<DOC>
	<DOCNO>NCT02535468</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness T2Bacteria Panel validate clinical performance ( i.e . estimate sensitivity specificity ) T2Bacteria Panel compare blood culture result and/or known Bacteria positive status prospectively collect clinical specimen contrive ( i.e . Bacteria-spiked ) whole blood `` clinical sample '' .</brief_summary>
	<brief_title>T2Bacteria Panel Pivotal Study</brief_title>
	<detailed_description />
	<mesh_term>Bacteremia</mesh_term>
	<criteria>Subject subject 's legally authorize representative ( LAR ) must able understand , read sign study specific informed consent form nature study fully explain . Subject diagnostic blood culture order , per routine standard care ( prospective arm ) . Subject 1895 year age . Subject comorbid condition ( ) , opinion Investigator , could limit subject 's ability participate study impact scientific integrity study . Subject previous specimen test T2Bacteria Panel valid result . Treatment subject investigational novel drug compound within 30 day prior collection T2 specimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>